Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Alaunos Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 149 | 3 | 125 | −21 |
| Shares | 100.5M | 114.8K | 73.4M | −27.0M (−26.9%) |
| Value | $65.8M | $74.0K | $90.7M | +$25.0M (+38.0%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 4,289,193 | $5.32M | 0.22% |
| Ergoteles LLC | 936,900 | $1.16M | 0.03% |
| Green Square Capital Advisors LLC | 849,500 | $1.05M | 0.19% |
| Marshall Wace, LLP | 626,531 | $777.0K | 0.00% |
| Kettle Hill Capital Management, LLC | 344,400 | $427.0K | 0.11% |
| Bank of Montreal | 182,800 | $231.0K | 0.00% |
| Qube Research & Technologies Ltd | 144,025 | $179.0K | 0.00% |
| Franklin Resources Inc | 133,783 | $166.0K | 0.00% |
| LMR Partners LLP | 99,692 | $124.0K | 0.00% |
| Blair William & Co | 93,729 | $116.0K | 0.00% |
| Sugarloaf Wealth Management, LLC | 76,550 | $95.0K | 0.02% |
| Atria Wealth Solutions, Inc. | 40,200 | $50.0K | 0.00% |
| SEI Investments Co | 30,600 | $38.0K | 0.00% |
| Balyasny Asset Management LLC | 30,759 | $38.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 25,079 | $31.0K | 0.00% |
| Verition Fund Management LLC | 24,295 | $30.0K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 14,275 | $18.0K | 0.00% |
| Cetera Advisor Networks LLC | 13,418 | $17.0K | 0.00% |
| Pinz Capital Management, LP | 10,900 | $14.0K | 0.01% |
| ACG Wealth | 162 | $0 | 0.00% |
| Geneos Wealth Management Inc. | 491 | $0 | 0.00% |
Sold out (42)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (3)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 75,584 | $49.0K |
| Amalgamated Financial Corp. | 34,236 | $22.0K |
| Lenox Wealth Advisors, LLC | 5,000 | $3.00K |